AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
3 Unstoppable Dividend Stocks to Buy Right Now
Investors will get great dividends and more with these stocks.
2 High-Yield Dividend Stocks to Buy in August and Hold for a Decade or Longer
These high-yield dividend stocks are built to last.
If You'd Invested $1,000 in AbbVie Stock 10 Years Ago, Here's How Much You'd Have Today
You'd be sitting pretty right now.
3 Dividend Stocks to Double Up On Right Now
These stocks offer great dividends and more.
The Largest Healthcare Companies by Market Cap in August 2025
Eli Lilly, Johnson & Johnson, and AbbVie command the healthcare sector.
My 3 Favorite Stocks to Buy Right Now
These tried-and-true businesses are performing well against a volatile backdrop.
Investing in Pharmaceutical Stocks
4 of My Favorite Dividend Stocks for the Next 5 Years
All four pay safe, reliable, and growing dividends.
Valuation
Earnings Transcripts
AbbVie (ABBV) Q2 2025 Earnings Call Transcript
None
AbbVie (ABBV) Q4 2024 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2024.
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.